897 — Wai Yuen Tong Medicine Holdings Balance Sheet
0.000.00%
- HK$399.41m
- HK$632.60m
- HK$783.88m
- 50
- 65
- 72
- 71
Annual balance sheet for Wai Yuen Tong Medicine Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 591 | 667 | 645 | 579 | 197 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 239 | 242 | 176 | 195 | 217 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,096 | 3,234 | 2,889 | 2,702 | 830 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 975 | 962 | 956 | 961 | 665 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 7,730 | 7,965 | 7,598 | 7,014 | 2,095 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,874 | 2,371 | 1,881 | 1,657 | 381 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 5,087 | 5,399 | 5,082 | 4,665 | 708 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,643 | 2,565 | 2,516 | 2,349 | 1,387 |
Total Liabilities & Shareholders' Equity | 7,730 | 7,965 | 7,598 | 7,014 | 2,095 |
Total Common Shares Outstanding |